Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: miR-22/KAT6B axis is a chemotherapeutic determiner via regulation of PI3k-Akt-NF-kB pathway in tongue squamous cell carcinoma

Fig. 1

High expression level of miR-22 correlates with pathological complete response (pCR) and higher disease-free survival (DFS). a, Expression levels of miR-22 in tongue cancer patients (n = 56, 28 pCR vs 28 non-pCR), who received CDDP regimen chemotherapy, were quantitated by real-time PCR. RNU6 was used as an internal control. Data are mean ± s.e.m. b, Kaplan–Merier curves of 56 tongue cancer patients after stratification by the level of miR-22 were used for depicting DFS. c, Receiver operating characteristic (ROC) curve of 56 oral cancer patients’ level of miR-22 was used for analyzing the area under the curve (AUC) value

Back to article page